3P BIOTECH NORWAY AS: årsregnskap 2012 vs 2011
Mixed movements in the accounts
Summary
What changed
Comparing Årsregnskap 2012 with 2011 for 3P BIOTECH NORWAY AS. Equity -25.4k NOK → -51.0k NOK.
Pressures included: operating result weakened; equity eroded.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
Operating result
-4 871 NOK
-25.6k NOK
-426.4%
Equity
-25.4k NOK
-51.0k NOK
-101.0%
Cash
n/m
10.7k NOK
—
Total assets
107.0k NOK
107.0k NOK
0.0%
What deteriorated
-
↓
Operating result weakened
Operating result -4 871 NOK → -25.6k NOK. Calculated
-
↓
Equity eroded
Book equity -25.4k NOK → -51.0k NOK (equity ratio -23.7% → -47.7%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -47.7% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation